How Kangmei Pharma Cut Revenue but Boosted Earnings by 600%
First‑9‑month review: Kangmei Pharma cuts revenue 11% yet slashes costs, boosts margins, and earns 600% higher profit thanks to asset sales, debt settlements, and disciplined cost control – but cash flow dips 30%. Click to see how it balances short‑…
3 minutes to read